VCLS Receives EcoVadis Silver Rating
VCLS has received a “silver” rating in the 2023 EcoVadis Sustainability Rating Program. This is the second time that VCLS…
VCLS Welcomes Accomplished Alain Robbe as Managing Director
Jan 04 2024, Paris Voisin Consulting Life Sciences (VCLS), a leading global HealthTech solution provider, offering end-to-end solutions from preclinical…
VCLS Microbiome Team announced as Winner of the TOPRA Award for Communication 2023
The VCLS Microbiome Team was humbled to learn that they had won the international TOPRA Award for Communication during the…
VCLS Acquires MedEngine to Create a Global Scientific Consortium for Innovative Therapies, from Lab to…
Paris, France, October 31st, 2023 Voisin Consulting Life Sciences (VCLS), a prominent global HealthTech solution provider offering end-to-end solutions from…
VCLS obtains ISO/IEC 27001 certification
April 17th, 2023, Paris, France Voisin Consulting Life Sciences (VCLS), a leading global HealthTech solution provider, offering end-to-end solutions from preclinical…
VCLS announces new presence in Cambridge, UK
Paris, France, August 23, 2022 We are delighted to confirm St John’s Innovation Centre, Cambridge, UK as the latest VCLS…
VCLS Announces New Strategic Partnership With EC Innovations in China
Paris, France, April 19, 2022 Voisin Consulting Life Sciences (VCLS), a leading global regulatory, access to market and clinical consultancy,…
Ask the experts: Will you be ready for the new IVD regulation?
The major switch from IVD directive to IVD regulation is happening next year on the 26th May 2022. Notified Bodies…